Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients

International Journal of Cardiology

Volumn 108, Issue 1, 2006, Pages 63-67

  Hogenhuis, Jochem ^a   Jaarsma, Tiny ^a   Voors, Adriaan A ^a   Hillege, Hans L ^a   Lesman, Ivonne ^a   Van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

6MWT; BNP; Heart failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXERCISE TEST; FEMALE; FUNCTIONAL STATUS; HEALTH SURVEY; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SIX MINUTE WALK TEST; WALKING;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; WALKING;

EID: 33644641110     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.04.007     Document Type: Article

References (31)

1. M. Mukoyama, K. Nakao, and Y. Saito Increased human brain natriuretic peptide in congestive heart failure N Engl J Med 323 1990 757 758
2. S.J. Wieczorek, A.H. Wu, and R. Christenson A rapid B-type natriuretic peptide assay accuracy diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation Am Heart J 144 2002 834 839
3. G.H. Guyatt, M.J. Sullivan, and P.J. Thompson The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure Can Med Assoc J 132 1985 919 923
4. P. Bettencourt, A. Ferreira, and P. Dias Predictors of prognosis in patients with stable mild to moderate heart failure J Card Fail 6 2000 306 313
5. R. Isnard, F. Pousset, and O. Chafirovskaia Combination of B-type natriuretic peptide and peak oxygen consumption risk stratification in outpatients with chronic heart failure Am Heart J 146 2003 729 735
6. P. Mantymaa, O. Vuolteenaho, M. Marttila, and H. Ruskoaho Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro Endocrinology 133 1993 1470 1473
7. A.M. Richards, I.G. Crozier, T.G. Yandle, H. Ikram, and M.G. Nicholls Brain natriuretic factor-regional plasma concentrations and correlations with hemodynamic state in cardiac disease Br Heart J 69 1993 414 417
8. R.J. Bain, L.B. Tan, R.G. Murray, M.K. Davies, and W.A. Littler The correlation of cardiac power output to exercise capacity in chronic heart failure Eur J Appl Physiol 61 1990 112 118
9. J.A. Franciosa, M. Park, and T.B. Levine Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure Am J Cardiol 47 1981 33 39
10. K. Dracup, J.A. Walden, L.W. Stevenson, and M.L. Brecht Quality of life in patients with advanced heart failure J Heart Lung Transplant 11 1992 273 279
11. S.A. Van den Broek, D.J. Van Veldhuisen, P.A. De Graef, M.L. Landsman, H. Hillege, and K.I. Lie Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 70 1992 359 363
12. G. Jondeau, S.D. Katz, and L. Zohman Active skeletal muscle mass and cardiopulmonary reserve-failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure Circulation 86 1992 1351 1356
13. I.C. Steele, A. Moore, and A.M. Nugent Non-invasive measurement of cardiac output and ventricular ejection fractions in chronic cardiac failure: relationship to impaired exercise tolerance Clin Sci 93 1997 195 203
14. P. Jourdain, F. Funck, and M. Bellorini Bedside B-type natriuretic peptide and functional capacity in chronic heart failure Eur J Heart Fail 5 2003 155 160
15. S.J. Wieczorek, D.F. Hager, M.B. Barry, L. Kearney, A. Ferrier, and A.H. Wu Correlation of B-type natriuretic peptide level to 6-min walk test performance in patients with left ventricular systolic dysfunction Clin Chim Acta 328 2003 87 90
16. L. Zanolla, and P. Zardini Selection of endpoints for heart failure clinical trials Eur J Heart Fail 5 2003 717 723
17. M. Metra, S. Nodari, and D. Raccagni Maximal and submaximal exercise testing in heart failure J Cardiovasc Pharmacol 32 1998 S36 S45
18. G.H. Guyatt, P.J. Thompson, and L.B. Berman How should we measure function in patients with chronic heart and lung disease? J Chronic Dis 38 1985 517 524
19. T. Jaarsma, M.H.L vander Wal, and J. Hogenhuis Design and methodology of the COACH study: a multicenter randomised coordinating study evaluating outcomes of advising and counselling in heart failure Eur J Heart Fail 6 2004 227 233
20. V. Cheng, R. Kazanagra, and A. Garcia A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study J Am Coll Cardiol 37 2001 386 391
21. G. Tjeerdsma, R.A. de Boer, F. Boomsma, M.P. van den Berg, Y.M. Pinto, and D.J. van Veldhuisen Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure Int J Cardiol 86 2002 143 149
22. C. Demers, R.S. McKelvie, A. Negassa, S. Yusuf, and RESOLVD Pilot Study Investigators Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure Am Heart J 142 2001 698 703
23. T.S. Rector, S. Kubo, and J.N. Cohn Patient's self-assessment of their congestive heart failure: Part 2. Content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire Heart Fail 1 1987 198 209
24. J.E. Ware, and B. Gandek Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) Project J Clin Epidemiol 51 1998 903 912
25. B.C. Stein, and R.I. Levin Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease Am Heart J 135 1998 914 923
26. A.H. Wu, and A. Smith Biological variation of natriuretic peptides and their role in monitoring patients with heart failure Eur J Heart Fail 6 2004 355 358
27. W.S. Huang, M.S. Lee, H.W. Perng, S.P. Yang, S.W. Kuo, and H.D. Chang Circulating brain natriuretic peptide values in healthy men before and after exercise Metabolism 51 2002 1423 1426
28. A. Luchner, J.C. Burnett, M. Jougasaki, H.W. Hense, G.A. Riegger, and H. Schunkert Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study J Am Coll Cardiol 32 1998 1839 1844
29. J.G. Motwani, H. McAlpine, N. Kennedy, and A.D. Struthers Plasma brain natriuretic peptide as an indicator for angiotensin converting enzyme inhibition after myocardial infarction Lancet 341 1993 1109 1113
30. R. Kazanegra, V. Cheng, and A. Garcia A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study J Card Fail 7 2001 21 29
31. S.T. O'Keeffe, M. Lye, C. Donnellan, and D.N. Carmichael Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients Heart 80 1998 377 382